MED EBITDA Growth
Medifast Inc · EBITDA Growth
MED EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-100.63%period ending
MED TTM EBITDA YoY % (-726.67% → -100.63%)
Year-over-year change
High-resolution chart · PNG
MED ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -100.6263% | |
| 16.2236% | |
| -47.8387% | |
| -36.5582% | |
| -60.3843% | |
| -94.5693% | |
| -88.3908% | |
| -84.6888% | |
| -72.8485% | |
| -48.4239% | |
| -27.4284% | |
| -22.2664% | |
| -14.5952% | |
| -14.6956% | |
| -12.8733% | |
| -0.7489% | |
| 7.0337% | |
| 34.1714% | |
| 58.8882% | |
| 75.6272% | |
| 108.9303% | |
| 76.7529% | |
| 45.2088% | |
| 23.7091% | |
| 2.9436% | |
| 15.1693% | |
| 32.5165% | |
| 55.1257% | |
| 67.6627% | |
| 65.9091% | |
| 67.6467% | |
| 53.7247% | |
| 40.6813% | |
| 47.8722% | |
| 35.8821% | |
| 29.9179% | |
| 28.1295% | |
| -3.4432% | |
| -9.8746% | |
| -15.5065% | |
| -13.923% | |
| -6.4179% | |
| -12.5958% | |
| -11.8431% | |
| -17.6847% | |
| -16.9523% | |
| -8.9256% | |
| 3.57% | |
| 2.5359% | |
| 22.195% | |
| 30.4784% | |
| 26.3305% | |
| 46.247% | |
| 12.413% | |
| -5.0156% | |
| -15.6039% | |
| -26.9087% | |
| -16.979% | |
| -3.6509% | |
| 3.2961% | |
| 19.6335% | |
| 37.1431% | |
| 52.6198% | |
| 80.2436% | |
| 93.1889% | |
| 95.127% | |
| 93.1815% | |
| 72.0905% | |
| 59.7759% | |
| 53.1919% | |
| 34.2935% | |
| 192.3272% | |
| 182.9701% | |
| 175.5151% | |
| 179.5584% | |
| -230.9991% | |
| -240.3787% | |
| -255.3448% | |
| -305.6062% | |
| 74.5828% | |
| 92.9618% | |
| 85.0469% | |
| 34.7937% | |
| 37.7783% | |
| 18.3728% | |
| 13.2085% | |
| 0.9123% | |
| 13.8292% | |
| 13.2227% | |
| 21.0784% | |
| 106.2229% | |
| 76.6423% | |
| 157.6622% | |
| 235.1129% | |
| 93.9196% | |
| 64.0121% | |
| 18.587% | |
| 4.7312% | |
| 51.8466% | |
| 87.2756% |